⏳ Launch offer ends in...
- 00Days
- 00Hrs
- 00Mins
- 00Secs
Connecting Innovators with Strategic Knowledge & Capital
September 11th - 12th, 2024Hynes Convention Centre, Boston, MA, USAKey Sessions
Alexandra Taracanova
Revolutionizing the Future: Unveiling the Dynamics of Biotech Investment and Deals in the USA
RTW Investments
Tadaaki Taniguchi
Pharma Keynote: Pioneering Partnerships: Building Alliances that Push the Boundaries of Science in Underserved Diseases
Astellas Pharma
Garrett Rhyasen
The Pill-ar of Success: Navigating Pharma Collaborations and Spotting Innovation
GSK
Elizabeth Garner
Navigating the USA Landscape for Gender Equality in Women's Health
Ferring Pharmaceuticals
Carla Peron
Sustained Success - A Holistic Review of MedTech in 2024
Philips
Ziv Bar-Joseph
Defining our AI Future – Operationalising AI to Deliver Business & Patient Benefits
Sanofi
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day 1 – Wednesday, 11 SEPTEMBER - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Formats
Day 1 – Wednesday, 11 SEPTEMBER - ET (Eastern Time, GMT-05:00)
search
Streams
Clear
Formats
Showing 1 of 1 Streams
BIOTECH LEADERS MORNING KEYNOTE PLENARY
9:00am - 9:05am
WELCOME ADDRESS
- Adam Griffiths - Senior Director, Biotech Lead, Informa
9:05am - 10:00am
Revolutionizing the Future: Unveiling the Dynamics of Biotech Investment and Deals in the USA
- Alexandra Taracanova - VP, RTW Investments
- Adam Schoen - Partner, Brown Rudnick
- Issi Rozen - General Partner, Google Ventures
- Richard Kivel - CEO, Graybella Capital
- Bibhash Mukhopadhyay - Managing Partner & Co-Founder, Sound Bioventures
10:00am - 10:30am
Pharma Keynote: Pioneering Partnerships: Building Alliances that Push the Boundaries of Science in Underserved Diseases
- Tadaaki Taniguchi - Chief Medical Officer, Astellas Pharma
Showing 3 of 3 Streams
CAPITAL MARKETS & INVESTMENT
PARTNERSHIPS & DEAL MAKING
SCALING & COMMERCIALISATION
11:00am - 11:50am
The Venture Investor Outlook and Investing in the Therapies of Tomorrow
- Stephen Squinto - Chief Investment Officer, JP Morgan Life Sciences
- Ralf Saykiewicz - Managing Partner, Raudi Capital
- Rebecca Luse - Principal, Deep Track Capital
11:50am - 12:40pm
Understanding Shifts in Early-Stage VC Investment Criteria
- Stephen Bruso - Partner, Morningside Advisory
- John Boyce - Managing Director & Co-Founder, TigerGene
- Soyoung Park - Managing Director, 2080 Ventures
11:00am - 11:50am
The Pill-ar of Success: Navigating Pharma Collaborations and Spotting Innovation
- Garrett Rhyasen - VP, Head of Search, Evaluation, & Transactions, GSK
- Adam Feire - Global Head Search & Evaluation, Corporate & Business Development, Novartis
- Jeremy O’Hanlon - Executive Director, Global BD, Daiichi-Sankyo
- Alison Hogg - Executive Director, Corporate Development, Gilead Sciences
11:50am - 12:40pm
Driving Innovation in Life Sciences Through Fostering Strong Partnerships Between Industry, Academia, and NPOs
- Alfred Slanetz - Chairman, National Foundation for Cancer Research
- James Zanewicz - CBO, Tulane University
- Peter Meinke - Sanders Director, Tri-Institutional Therapeutics Discovery Institute
11:00am - 11:50am
Funding Biotech Innovation and Scaling Up
- Ellen Donnelly - CEO, Abliva
- Paul-Peter Tak - CEO, Candel Therapeutics
- Jenny Barnett - CEO, Monument Therapeutics
11:50am - 12:40pm
Integrating CMC Development for Value Creation in Biotech Start-Ups
- Doug Danison - Head, Commercial Strategy & Operations, Cell & Gene Therapies, Bayer
- Robert Sexton - VP, Program & Alliance Leadership, Mustang Bio
- Sohail Zaidi - CEO, Ananda Scientific
Showing 3 of 3 Streams
CAPITAL MARKETS & INVESTMENT
PARTNERSHIPS & DEAL MAKING
SCALING & COMMERCIALISATION
1:40pm - 2:30pm
Pitch Perfect: What to Show Private Investors Within a Turbulent Market
- Chris Carpenter - Executive Partner, Sofinnova
- Michael Goldberg - CEO, Surge Therapeutics
- Elaine Yang - Director, ORI Capital
2:30pm - 3:20pm
The CVC Perspective: Strategic Venturing in Biotech Throughout 2024 & Beyond
- Marian Nakada - VP, Venture Investments, JJDC
- Aaron Nelson - Managing Director, Novartis Venture Fund
- Fei Shen - Managing Director, Boehringer Ingelheim Venture Fund
1:40pm - 2:30pm
The Oncology Odyssey: Exploring New Market Trends In Cancer Research and Partnering
- Natalia Ulyanova - Business Development Director, Oncology, Astellas, USA
- Dan Passeri - CEO, Cue Biopharma
- Matt Britz - CEO, AffyImmune Therapeutics
2:30pm - 3:20pm
Navigating the USA Landscape for Gender Equality in Women's Health
- Elizabeth Garner - CSO, Ferring Pharmaceuticals
- Elizabeth Bailey - Managing Director, RH Capital
- Carolee Lee - CEO & Founder, WHAM
1:40pm - 2:30pm
Commercialization Strategies for Biotechs and Early-Planning
- Joe Goldberg - Partner, RSM US LLP
- Dan Oliver - CEO, Rejuvenate Bio
- Michelle Chen - CBO, Insilico Medicine
- Jeff Landau - CBO, CytomX
2:30pm - 3:20pm
Developing an Effective Message and Strategic Positioning in a Crowded Market
- David Brower - CBO, Accent Therapeutics
- Daniel Silva Manzano - CEO, Monod Bio
- Jae Won Kim - COO/CFO, VantAI
- Kimberly Ha - Founder & CEO, KKH Advisors
Showing 1 of 1 Streams
BIOTECH LEADERS AFTERNOON KEYNOTE PLENARY
3:50pm - 4:40pm
Maximizing Returns: Unleashing the Power of AI for Tangible ROI
- Kamni Vijay - CEO, Enable Medicine
- Mark Stead - Head of BD, Atomic AI
- Greg Ryslik - CTO, COMPASS Pathways
- Elizabeth Schwarzbach - CBO, BigHat Biosciences
4:40pm - 5:30pm
Pharma Fusion: Spearheading Growth Through M&A and Partnering in 2024
- Philippe Lopes-Fernandes - EVP, CBO, Ipsen
- Issei Tsukamoto - SVP, Global Head Business Development, Astellas
- Sarah Kilpatrick - VP Business Development, Pfizer
- Julie Rozenblyum - SVP, BD, Bristol Myers Squibb
Get the Latest Event Updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear
Formats